Articles with public access mandates - Michele CaragliaLearn more
Not available anywhere: 7
Review
PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy
GI Manfredi, A Dicitore, G Gaudenzi, M Caraglia, L Persani, G Vitale
Endocrine 48, 363-370, 2015
Mandates: Government of Italy
Review
Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferation
A Dicitore, M Caraglia, G Gaudenzi, G Manfredi, B Amato, D Mari, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 42-52, 2014
Mandates: Government of Italy
Review
Expression and localization of serine protease Htra1 in neuroblastoma: correlation with cellular differentiation grade
V D’Angelo, G Pecoraro, P Indolfi, A Iannotta, V Donofrio, ME Errico, ...
Journal of neuro-oncology 117, 287-294, 2014
Mandates: Government of Italy
Review
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC
R Addeo, S Zappavigna, A Luce, S Facchini, M Caraglia
Expert opinion on drug safety 12 (5), 729-740, 2013
Mandates: Government of Italy
Review
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat
C Carbone, E Di Gennaro, G Piro, MR Milone, B Pucci, M Caraglia, ...
Amino acids 49 (3), 517-528, 2017
Mandates: Government of Italy
Review
Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation
A Dicitore, ES Grassi, MO Borghi, G Gelmini, MC Cantone, G Gaudenzi, ...
Journal of Endocrinological Investigation 40, 761-770, 2017
Mandates: Government of Italy
Review
Structural characterization of self-assembling hybrid nanoparticles for bisphosphonate delivery in tumors
S Ristori, I Grillo, S Lusa, J Thamm, G Valentino, V Campani, M Caraglia, ...
Molecular pharmaceutics 15 (3), 1258-1265, 2018
Mandates: US National Science Foundation
Available somewhere: 74
Review
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health, US …
Review
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
Mandates: US National Institutes of Health
Review
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
Mandates: US National Institutes of Health
Review
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
L Mele, F Paino, F Papaccio, T Regad, D Boocock, P Stiuso, A Lombardi, ...
Cell death & disease 9 (5), 572, 2018
Mandates: Government of Italy
Review
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib
P Stiuso, N Potenza, A Lombardi, I Ferrandino, A Monaco, S Zappavigna, ...
Molecular Therapy-Nucleic Acids 4, 2015
Mandates: Government of Italy
Review
Micrornas in prostate cancer: an overview
D Vanacore, M Boccellino, S Rossetti, C Cavaliere, C D'Aniello, ...
Oncotarget 8 (30), 50240, 2017
Mandates: Government of Italy
Review
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
MT Di Martino, V Campani, G Misso, ME Gallo Cantafio, A Gulla, ...
PloS one 9 (2), e90005, 2014
Mandates: Government of Italy
Review
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy
M Rossi, B Rotblat, K Ansell, I Amelio, M Caraglia, G Misso, F Bernassola, ...
Cell death & disease 5 (5), e1203-e1203, 2014
Mandates: UK Medical Research Council, Government of Argentina
Review
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma
N Amodio, MA Stamato, AM Gullà, E Morelli, E Romeo, L Raimondi, ...
Molecular cancer therapeutics 15 (6), 1364-1375, 2016
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Review
eIF5A isoforms and cancer: two brothers for two functions?
M Caraglia, MH Park, EC Wolff, M Marra, A Abbruzzese
Amino acids 44, 103-109, 2013
Mandates: US National Institutes of Health
Review
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
M Colombino, P Sperlongano, F Izzo, F Tatangelo, G Botti, A Lombardi, ...
Cell death & disease 3 (1), e259-e259, 2012
Mandates: Government of Spain
Review
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study
P Stiuso, I Scognamiglio, M Murolo, P Ferranti, C De Simone, MR Rizzo, ...
Oxidative medicine and cellular longevity 2014 (1), 169216, 2014
Mandates: Government of Italy
Review
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
C Ieranò, S Santagata, M Napolitano, F Guardia, A Grimaldi, E Antignani, ...
Cell death & disease 5 (7), e1310-e1310, 2014
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program